The filing of a class action lawsuit against Novo Nordisk A/S is likely to create uncertainty among investors, potentially leading to a decline in stock price as they assess the legal risks and potential financial liabilities. The deadline for joining the lawsuit is March 25, 2025, which may keep the issue in focus for investors in the short term.